![PDF) Design and development of masked therapeutic antibodies to limit off-target effects Application to anti-EGFR antibodies PDF) Design and development of masked therapeutic antibodies to limit off-target effects Application to anti-EGFR antibodies](https://www.researchgate.net/profile/Ulrich-Rodeck/publication/26840719/figure/fig2/AS:601668823560223@1520460434997/Design-production-and-characterization-of-cross-masked-425-C225-scFvs-a-Topology-of_Q320.jpg)
PDF) Design and development of masked therapeutic antibodies to limit off-target effects Application to anti-EGFR antibodies
![Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy - Durrant - 2012 - Clinical & Experimental Immunology - Wiley Online Library Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy - Durrant - 2012 - Clinical & Experimental Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/bb6404ad-0671-4946-b53b-22c242a8b002/cei_4516_f2.gif)
Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy - Durrant - 2012 - Clinical & Experimental Immunology - Wiley Online Library
INTZ - SORTEIO do G2A.COM - OLOCO MEU! Concorra a um caminhão de prêmios direto do baú da G2A, Cougar e INTZ. Para participar é simples e grátis, acesse: -»> intz.club/sorteio-g2a
Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung canc
![PDF) Design and development of masked therapeutic antibodies to limit off-target effects Application to anti-EGFR antibodies PDF) Design and development of masked therapeutic antibodies to limit off-target effects Application to anti-EGFR antibodies](https://www.researchgate.net/profile/Ulrich-Rodeck/publication/26840719/figure/fig3/AS:601668827754501@1520460435055/Binding-analysis-of-cross-masked-425-C225-scFvs-a-surface-plasmon-resonance-analysis_Q320.jpg)
PDF) Design and development of masked therapeutic antibodies to limit off-target effects Application to anti-EGFR antibodies
Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy
![Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy - Durrant - 2012 - Clinical & Experimental Immunology - Wiley Online Library Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy - Durrant - 2012 - Clinical & Experimental Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2ce38c9c-06e3-464b-b436-cfdbb51d1787/cei_4516_f1.gif)